Published: Mar 11, 2026
Written by Klarity Editorial Team
Published: Mar 11, 2026

If you’ve been feeling exhausted, struggling with low libido, or noticing a dip in your mood and energy, low testosterone might be the culprit. The good news? In 2025, you don’t necessarily need to schedule an in-person doctor’s visit to get evaluated and treated for low T. Telehealth has opened new doors for men seeking hormone therapy—but navigating the rules, regulations, and best practices can feel overwhelming.
This guide breaks down everything you need to know about accessing low testosterone treatment through telehealth, from federal and state regulations to what legitimate online care should look like.
Telehealth for low testosterone means connecting with a licensed healthcare provider remotely—typically through video consultations—to discuss your symptoms, review lab results, and receive a prescription if appropriate. This approach has become increasingly popular, especially after COVID-19 accelerated the adoption of virtual care.
What makes telehealth treatment legitimate? A credible telehealth provider will:
At Klarity Health, we follow these clinical standards while making care more accessible. Our providers are licensed in your state, and we work with both insurance and cash-pay patients to ensure transparent pricing and convenient access to treatment.
The Drug Enforcement Administration (DEA) normally requires an in-person medical examination before prescribing controlled substances—including testosterone, which is a Schedule III controlled drug. However, during the COVID-19 pandemic, the DEA suspended this requirement to expand telehealth access.
Current Status (as of December 2025):
The DEA has extended COVID-era telehealth flexibilities through December 31, 2025. This means healthcare providers can currently prescribe testosterone and other controlled substances via telemedicine without an initial in-person visit. This marks the third extension since the pandemic emergency ended, and stakeholders are pushing for Congress to make these changes permanent.
What about non-controlled medications? Medications like Clomiphene citrate (Clomid)—sometimes prescribed off-label for low testosterone—are not controlled substances. The DEA’s in-person requirement never applied to these medications, meaning they can be prescribed via telehealth without federal restrictions.
Looking ahead: The DEA has proposed new telemedicine regulations that would require a special registration system for providers, but no final rules have been implemented yet. Patients and providers should monitor for potential changes after 2025, though many experts expect further extensions given the success of telehealth programs.
While federal rules set a baseline, individual states have their own telehealth regulations that can be more restrictive. Here’s what you need to know about key states:
California, Texas, Delaware, New York, and New Hampshire have embraced telehealth prescribing with minimal restrictions. In these states, providers can establish a patient relationship via video consultation and prescribe low testosterone treatments without requiring an in-person visit for non-controlled medications.
California recently considered legislation (AB 1503) that would further modernize telehealth by allowing asynchronous evaluations (like detailed questionnaires) to qualify as an appropriate prior examination for certain prescriptions.
New Hampshire made significant changes in 2025 by eliminating previous in-person exam requirements for controlled substance prescribing via telehealth. Providers can now prescribe Schedule II-IV medications remotely, provided patients receive an in-person evaluation at least every 12 months from any licensed prescriber.
Georgia requires patients to be examined in person by a Georgia-licensed provider before telehealth treatment begins, or through a referral from another provider. Additionally, Georgia mandates at least an annual attempt at an in-person examination for ongoing care.
Alabama allows telehealth but requires an in-person visit within 12 months if you receive telehealth treatment more than four times for the same condition.
Florida permits telehealth prescribing for Schedule III-V controlled substances (which includes testosterone), but maintains restrictions on Schedule II drugs via telehealth except in specific settings like psychiatric care, hospice, or nursing homes.
Regardless of which state you’re in, your telehealth provider must be licensed in your state of residence. Interstate telehealth compacts exist for some professions, but for prescribing medications—especially controlled substances—state licensure is mandatory. Legitimate telehealth platforms like Klarity Health ensure all providers are properly licensed in the states where they practice.
Not all healthcare providers have the same prescriptive authority, and this varies significantly by state.
Medical doctors and doctors of osteopathic medicine can prescribe all testosterone treatments and related medications in every state, subject to telehealth rules.
Nurse practitioner authority varies widely:
PAs generally require a supervising physician agreement regardless of state. Most states allow PAs to prescribe Schedule III-V controlled substances (including testosterone) when properly delegated by their supervising physician.
At Klarity Health, our network includes physicians, nurse practitioners, and physician assistants—all credentialed and authorized to provide low testosterone treatment in their respective states.
Forms available:
DEA Classification: Schedule III controlled substance
Telehealth Status: Can be prescribed via telehealth under current federal flexibilities (extended through December 31, 2025). State rules apply.
Considerations: TRT directly replaces testosterone but can suppress natural production and may affect fertility. Regular monitoring of testosterone levels, red blood cell counts, and prostate health is essential.
What it is: A selective estrogen receptor modulator (SERM) FDA-approved for female fertility but commonly prescribed off-label for male hypogonadism.
DEA Classification: Not a controlled substance
Telehealth Status: Can be prescribed via telehealth in all states with standard telehealth rules (no federal in-person requirement).
How it works: Clomid stimulates the body’s own testosterone production by blocking estrogen receptors in the hypothalamus and pituitary gland, increasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion.
Benefits: Unlike testosterone replacement, Clomid preserves fertility and natural testosterone production. It’s often chosen by younger men or those planning to have children.
Typical dosing: 25-50 mg daily or every other day, adjusted based on lab results.
What it is: A hormone that mimics LH, stimulating the testes to produce testosterone.
Use in Low T: Often prescribed alongside TRT to maintain testicular function and fertility, or as monotherapy for younger men.
Telehealth Status: Can be prescribed remotely under current regulations.
A proper telehealth evaluation for low testosterone should mirror the thoroughness of an in-person visit:
Red flags to avoid: Any service offering prescriptions based solely on a questionnaire without live provider consultation, or promising treatment without requiring lab confirmation of low testosterone.
Legitimate low testosterone diagnosis requires laboratory confirmation. According to American Urological Association (AUA) guidelines, diagnosis should be based on:
Your telehealth provider should either review recent lab results (typically within 6-12 months) or order new testing through a local lab before prescribing treatment.
Responsible telehealth low T treatment includes regular follow-ups:
Klarity Health structures care around these monitoring intervals, making it easy to schedule follow-up appointments and ensuring your treatment remains safe and effective.
Low testosterone treatment isn’t appropriate for everyone. Telehealth providers should screen for contraindications:
Your telehealth provider should discuss these risks thoroughly and ensure you’re a good candidate for treatment.
Most health insurance plans cover testosterone replacement therapy when medically necessary (documented low testosterone with symptoms). Coverage for telehealth visits has expanded significantly, with many insurers now treating virtual appointments the same as in-person visits for reimbursement.
What’s typically covered:
What may not be covered:
At Klarity Health, we accept major insurance plans and verify your coverage before your first appointment. For patients paying out-of-pocket, we offer transparent, upfront pricing—no surprise bills or hidden fees.
For those without insurance or seeking more privacy, cash-pay telehealth services offer an alternative. Typical costs include:
Klarity Health provides clear pricing for both insured and cash-pay patients, so you know exactly what to expect.
With the growth of online men’s health services, not all platforms are created equal. Here’s what to look for:
✅ Licensed providers in your state: Verify that physicians or NPs are properly credentialed✅ Required lab confirmation: No legitimate provider prescribes testosterone without documented low levels✅ Live consultations: Real-time video or phone appointments, not just questionnaires✅ Transparent pricing: Clear information about costs before you commit✅ Proper pharmacy partnerships: Prescriptions sent to licensed U.S. pharmacies, not shipped from overseas✅ Follow-up care: Structured monitoring and ongoing provider access✅ Evidence-based treatment: Following clinical guidelines and standard of care
🚩 Prescriptions without labs or consultation🚩 ‘No questions asked’ promises🚩 Providers not licensed in your state🚩 Extremely low prices that seem too good to be true🚩 Shipping medications directly without pharmacy involvement🚩 Aggressive marketing promising dramatic results🚩 No clear medical credentials for providers
Recent federal enforcement actions highlight the importance of choosing carefully. In 2025, prosecutors convicted the founder of a telehealth startup for running a $100 million fraud scheme that prescribed 40 million Adderall pills without proper examinations. While this case involved ADHD medication, it underscores the risks of platforms that prioritize profits over patient safety.
Most states require healthcare providers to check a state prescription monitoring database before prescribing controlled substances. This helps prevent doctor shopping and identifies patients who may be receiving opioids, benzodiazepines, or other controlled medications from multiple sources.
For testosterone (Schedule III), requirements vary:
Clomid doesn’t require PMP checks since it’s not a controlled substance, but responsible providers will still review your medication history.
Many states now mandate electronic prescribing (e-prescribing) for all medications, including controlled substances. This improves safety, reduces prescription fraud, and creates a clear audit trail. Legitimate telehealth platforms use certified e-prescribing systems that comply with DEA requirements.
The current DEA telehealth flexibilities are set to expire on December 31, 2025. What comes next?
1. Further Extension: The DEA could extend flexibilities again into 2026, as it has done three times already. Many healthcare organizations and patient advocacy groups are lobbying for this outcome.
2. Congressional Action: Congress could pass legislation making telehealth prescribing changes permanent, removing uncertainty for both providers and patients.
3. New DEA Rules: The agency could implement its proposed special registration system, which might require:
4. Return to Pre-Pandemic Rules: If flexibilities expire without replacement, the Ryan Haight Act’s in-person requirement would resume for controlled substances, requiring an initial in-person visit before prescribing testosterone via telehealth.
If you’re currently receiving testosterone via telehealth, stay informed about regulatory changes. However, even if stricter rules return:
Klarity Health is actively monitoring these developments and will ensure our patients maintain uninterrupted access to care regardless of regulatory changes.
While testosterone treatment can be life-changing for men with clinically low levels, it’s not a magic bullet for all health concerns. Legitimate providers consider low T in context:
Before jumping to hormone replacement, discuss with your provider:
A comprehensive telehealth provider will explore these factors alongside treatment options, creating a personalized plan that addresses root causes, not just symptoms.
Ready to explore whether low testosterone treatment through telehealth is right for you? Here’s how to get started:
Research telehealth platforms that specialize in men’s health and hormone therapy. Look for the credibility markers we discussed: licensed providers, required labs, transparent pricing, and structured follow-up care.
Book an initial video appointment. Most platforms, including Klarity Health, offer convenient online scheduling with same-day or next-day availability.
During your appointment, discuss symptoms thoroughly, review medical history, and work with your provider to order any needed lab work. If you already have recent results, the provider can review them during your visit.
If you meet criteria for low testosterone treatment, your provider will discuss options (TRT, Clomid, hCG, or combinations), prescribe appropriate medications, and set up a monitoring schedule.
Stick to your scheduled follow-up appointments—typically at 6 weeks, then every 3-6 months. Consistent monitoring ensures your treatment remains safe and effective.
At Klarity Health, we’ve designed our platform around what matters most: accessible, affordable, and evidence-based care. Here’s what sets us apart:
Our goal is to make quality men’s health care accessible without the hassle of traditional appointments, while maintaining the highest standards of medical practice.
Telehealth has transformed how men access low testosterone treatment, removing barriers like long wait times, inconvenient office hours, and geographic limitations. In 2025, you have more options than ever—but with that freedom comes responsibility to choose wisely.
Legitimate telehealth services like Klarity Health bridge the gap between accessibility and quality, ensuring you receive proper diagnosis, evidence-based treatment, and ongoing monitoring—all from the comfort of home.
Whether you’re just beginning to explore why you’re feeling off or you’re ready to take the next step toward treatment, telehealth puts expert care within reach. Just remember: while the medium has changed, the medicine hasn’t. Look for providers who prioritize your safety, follow clinical guidelines, and treat you as a whole person—not just a prescription.
Ready to take control of your energy, vitality, and well-being? Schedule a consultation with Klarity Health today. Our licensed providers are here to listen, evaluate, and create a personalized treatment plan that fits your life and goals.
This article reflects the regulatory landscape as of December 2025. DEA telemedicine flexibilities for controlled substance prescribing are currently extended through December 31, 2025, representing the third extension since pandemic emergency declarations ended. State telehealth laws continue to evolve, with recent 2025 changes in New Hampshire, California, and other jurisdictions expanding access. Readers should verify current federal and state regulations, as rules may change after publication. Klarity Health monitors regulatory developments and adapts our practices to ensure compliance while maintaining patient access to care.
U.S. Drug Enforcement Administration (DEA). ‘DEA and HHS Extend Telemedicine Flexibilities Through 2025.’ Official announcement, November 15, 2024. www.dea.gov
McDermott Will & Emery LLP. ‘DEA Signals Extension of Telemedicine Flexibilities into 2026.’ JD Supra legal analysis, November 19, 2025. www.jdsupra.com
Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and ‘In-Person’ Visits: A 50-State Survey of Emerging Requirements.’ Health Law blog, August 15, 2025. www.jdsupra.com
American Urological Association (AUA). ‘Testosterone Deficiency Guidelines.’ Clinical practice guidelines (reviewed 2024, originally published 2018). www.auanet.org
New Hampshire Legislature. ‘SB 252: An Act Relative to Controlled Drug Prescriptions Through Telemedicine.’ Signed into law, effective August 2025. legiscan.com
Additional verification sources include state medical boards (Texas Board of Nursing, California Medical Board), state prescription monitoring program guidelines, and federal statutes including the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. §829). All regulatory claims cross-referenced with 2024-2025 sources.
Find the right provider for your needs — select your state to find expert care near you.